Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 05 2023 - 5:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of April 2023
(Report No. 2)
Commission file number: 001-38041
SCISPARC LTD.
(Translation of registrant’s name into English)
20 Raul Wallenberg Street, Tower A,
Tel Aviv 6971916 Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
On
April 4, 2023, the Company issued a press release titled “SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial
for SCI-110 to treat Tourette Syndrome,” a copy of which is furnished as Exhibit 99.1 to this Form 6-K.
The first, second, third, fourth and seventh paragraphs and the
section titled “Forward-Looking Statements” in the press release attached hereto as Exhibit 99.1 are incorporated by
reference into the registration statements on Form F-3 (File No. 333-269839,
File No. 333-266047,
File No. 333-233417,
File No. 333-248670
and File No. 333-255408)
and on Form S-8 (File No. 333-225773)
filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the
extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
SciSparc Ltd. |
|
|
|
Date: April 4, 2023 |
By: |
/s/ Oz Adler |
|
Name: |
Oz Adler |
|
Title: |
Chief Executive Officer and
Chief Financial Officer |
Therapix Biosciences (NASDAQ:TRPX)
Historical Stock Chart
From May 2024 to Jun 2024
Therapix Biosciences (NASDAQ:TRPX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Therapix Biosciences Ltd (NASDAQ): 0 recent articles
More Scisparc Ltd. News Articles